InMed Pharmaceuticals (TSX:IN) Other Financing : C$-1.81 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is InMed Pharmaceuticals Other Financing?

InMed Pharmaceuticals's Other Financing for the three months ended in Dec. 2023 was C$0.00 Mil.

InMed Pharmaceuticals's Other Financing for the trailing twelve months (TTM) ended in Dec. 2023 was C$-1.81 Mil.

InMed Pharmaceuticals Other Financing Historical Data

The historical data trend for InMed Pharmaceuticals's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMed Pharmaceuticals Other Financing Chart

InMed Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Financing

Get a 7-Day Free Trial

0.05

-1.98

-2.29

-1.75

InMed Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Financing	Get a 7-Day Free Trial															0.78	-1.81	-	-	-

InMed Pharmaceuticals Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.81 Mil.

InMed Pharmaceuticals Other Financing Related Terms

Thank you for viewing the detailed overview of InMed Pharmaceuticals's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

InMed Pharmaceuticals (TSX:IN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InMed Pharmaceuticals Inc (TSX:IN) » Definitions » Other Financing

Comparable Companies

Traded in Other Exchanges

INM:USA MWG0:Germany

Address

815 West Hastings Street, Suite 310, Vancouver, BC, CAN, V6C 1B4

Website

https://www.inmedpharma.com

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

InMed Pharmaceuticals (TSX:IN) Headlines

No Headlines